A phase III study has shown that prophylactic cranial irradiation decreases the risk of symptomatic brain metastases and may improve overall survival for patients with extensive small-cell lung cancer and response to systemic chemotherapy.
A phase III study has shown that prophylactic cranial irradiation decreases the risk of symptomatic brain metastases and may improve overall survival for patients with extensive small-cell lung cancer and response to systemic chemotherapy.
Leave a Reply